ADIAL PHARMACEUTICALS, INC.·4

Mar 27, 6:07 PM ET

Truluck Joseph 4

4 · ADIAL PHARMACEUTICALS, INC. · Filed Mar 27, 2024

Insider Transaction Report

Form 4
Period: 2024-03-25
Truluck Joseph
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-03-25+25,00025,000 total
    Exercise: $1.35Exp: 2034-03-24Common Stock (25,000 underlying)
Footnotes (1)
  • [F1]The option vests pro rata on a monthly basis over 36 months commencing April 25, 2024.

Documents

1 file
  • 4
    ownership.xmlPrimary